These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26596034)

  • 21. Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia.
    Housman ST; Kuti JL; Nicolau DP
    Clin Chest Med; 2011 Sep; 32(3):439-50. PubMed ID: 21867814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
    Ferrer M; Menendez R; Amaro R; Torres A
    Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review.
    Russell CJ; Shiroishi MS; Siantz E; Wu BW; Patino CM
    BMC Pulm Med; 2016 Mar; 16():40. PubMed ID: 26956371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design.
    Niederman MS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S12-7. PubMed ID: 20597660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When can empiric therapy for intensive care unit-acquired pneumonia be withheld or withdrawn?
    Koeman M; Bonten MJ
    Semin Respir Infect; 2003 Jun; 18(2):122-8. PubMed ID: 12840793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.
    Sorbello A; Komo S; Valappil T; Nambiar S
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S36-41. PubMed ID: 20597669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled antibiotics for the treatment of pneumonia.
    Schreiber MP; Shorr AF
    Curr Opin Pulm Med; 2019 May; 25(3):289-293. PubMed ID: 30562188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.
    Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME
    Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.
    Abu-Salah T; Dhand R
    Adv Ther; 2011 Sep; 28(9):728-47. PubMed ID: 21833701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ventilator-associated pneumonia and multiresistant bacteria].
    Heininger A; Unertl K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):122-9. PubMed ID: 17309020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis.
    Ioannidou E; Siempos II; Falagas ME
    J Antimicrob Chemother; 2007 Dec; 60(6):1216-26. PubMed ID: 17934205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The research agenda in VAP/HAP: next steps.
    Niederman MS; Martin-Loeches I; Torres A
    Intensive Care Med; 2017 Sep; 43(9):1389-1391. PubMed ID: 28197677
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of ventilator-associated pneumonia.
    Diaz E; Ulldemolins M; Lisboa T; Rello J
    Infect Dis Clin North Am; 2009 Sep; 23(3):521-33. PubMed ID: 19665081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled anti-infective agents: emphasis on colistin.
    Michalopoulos A; Papadakis E
    Infection; 2010 Apr; 38(2):81-8. PubMed ID: 20191398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bartlett JG; Barie PS; Niederman MS; Wunderink RG
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-3. PubMed ID: 20597654
    [No Abstract]   [Full Text] [Related]  

  • 39. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia.
    Wood GC
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):993-1000. PubMed ID: 22029519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.